Sequential versus concomitant administration of docetaxel and gemcitabine as first-line treatment of advanced non-small cell lung cancer (NSCLC):: results of a phase II/III randomised study

被引：0
|
作者：
Manegold, C.
Thatcher, N.
Kortsik, C.
Koschel, G.
Spengler, W.
Mezgar, J.
Schott von Romer, K.
Pilz, L.
机构：
[1] Univ Mannheim, Med Ctr, Chirurg Klin, Mannheim, Germany
[2] Christie Hosp, Dept Clin Oncol, Manchester, Lancs, England
[3] Sankt Hildegardis Hosp, Catholic Clin Ctr, Mainz, Germany
[4] Gen Hosp Hamburg, Dept Lung & Bronchialkunde, Hamburg, Germany
[5] Schillerhohe Hosp Gerlingen, Stuttgart, Germany
[6] St Vincentius Hosp, Med Klin, Karlsruhe, Germany
[7] Thoraxklin, Heidelberg, Germany
[8] German Canc Res Ctr, D-6900 Heidelberg, Germany
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：326 / 326
页数：1
相关论文
共 50 条
  • [1] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel: second interim study results
    Mueller, Annette
    Thatcher, Nick
    Kortsik, Cornelius
    Koschel, Gabriele
    Spengler, Werner
    Pitz, Lothar R.
    Mezger, Joerg
    Manegold, Christian
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 168 - 169
  • [2] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results.
    Mueller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pilz, L
    Mezger, J
    Manegold, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 640S - 640S
  • [3] Gemcitabine and docetaxel as concomitant or sequential first-line therapy of advanced non-small cell lung cancer:: Updated results of a randomized study
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Piiz, L
    [J]. LUNG CANCER, 2005, 49 : S36 - S36
  • [4] A phase II/III randomized study in advanced non-small-cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel:: second interim study results
    Müller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pitz, LR
    Mezger, J
    Manegold, C
    [J]. LUNG CANCER, 2004, 45 : S76 - S76
  • [5] Concomitant versus sequential gemcitabine (G) and docetaxel (D) as first-line chemotherapy in advanced non-small-cell lung cancer (NSCLC):: updated outcomes and quality of life (QoL) results of a Phase II/III randomised study
    Thatcher, N
    Manegold, C
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Pilz, LR
    [J]. ANNALS OF ONCOLOGY, 2005, 16 : 306 - 306
  • [6] Docetaxel-gemcitabine versus cisplatin-gemcitabine plus sequential docetaxel in the first-line treatment of metastatic non-small cell lung cancer (NSCLC): interim results of a randomized Phase II trial
    Binder, Daniel
    Beinert, Thomas
    Schweisfurth, Hans
    Grah, Christian
    Temmestfeld-Wollbrueck, Bettina
    Schaeper, Christoph
    Mueller-Hagen, Gerit
    Schuermann, Dirk
    Suttorp, Norbert
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [7] Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC):: Results of a randomised phase II trial
    Binder, D
    Schweisfurth, H
    Grah, C
    Schäper, C
    Temmesfeld-Wollbrück, B
    Siebert, G
    Suttorp, N
    Beinert, T
    [J]. LUNG CANCER, 2005, 49 : S237 - S237
  • [8] Docetaxel/gemcitabine vs. a sequential protocol comprising cisplatin/gemcitabine/docetaxel in the first-line treatment of patients with stage IV non-small cell lung cancer (NSCLC):: results of a randomised phase II trial
    Binder, D.
    Schweisfurth, H.
    Grah, C.
    Schaper, C.
    Temmesfeld-Wollbruck, B.
    Siebert, G.
    Suttorp, N.
    Beinert, T.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [9] Phase II trial of gemcitabine and cisplatin as first-line treatment of advanced non-small cell lung cancer (NSCLC).
    Lee, NS
    Byun, JH
    Bae, SB
    Kim, CK
    Lee, KT
    Park, SK
    Park, KK
    Won, JH
    Hong, DS
    Park, HS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 701S - 701S
  • [10] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Eleni M. Karapanagiotou
    Adrianni Charpidou
    Ifigenia Tzannou
    Kalliopi Dilana
    Elias Kotteas
    Ioannis Tourkantonis
    Epaminondas Kosmas
    Aspasia Provata
    Kostas Syrigos
    [J]. Medical Oncology, 2008, 25 : 303 - 308
12345